A look at what's coming to Contemporary OB/GYN® this week.
Eating disorders carry many risks. An investigation looks into whether they can increase the risk of certain neurodevelopmental conditions in the children of mothers with a history of eating disorders.
The latest trial results showed statistically significant improvements in overall survival and progression-free survival.
Agile Therapeutics, Inc. recently announced a new alliance with Afaxys Pharma, LLC to promote levonorgestrel and ethinyl estradiol (Twirla®) transdermal system.
Check back soon for additional updates.
Study reports US health rankings to plummet by 2050
December 19th 2024Despite modest increases in life expectancy, the United States is set to fall behind globally in health-adjusted life expectancy because of rising obesity rates and other health risks, according to a comprehensive forecast.
Read More